Wirth Peter
- SEC CIK
- 0001021041
No open-market purchases or sales filed in the past year.
Current role at each company
- ZLAB Zai Lab LtdDirectoras of Jun 22, 2026
- Syros Pharmaceuticals, Inc.Directoras of Jun 7, 2024
- Forma Therapeutics Holdings, Inc.Directoras of Oct 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wirth Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZLAB Zai Lab Ltd
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 (view filing) | Dec 8, 2021 | 369 days | Wirth PeterDirector | PPurchaseAmerican Depositary Shares | +4.00K | $71.36 | +$285.4K | New position4.00K after | Amended |
| Dec 9, 2022 (view filing) | Dec 8 | 1 day | Wirth PeterDirector | SSaleAmerican Depositary Shares | −3.85K | $35.37 | −$136.2K | −1.1%342.8K after | |
| Dec 9, 2022 (view filing) | Dec 8 | 1 day | Wirth PeterDirector | SSaleAmerican Depositary Shares | −4.00K | $35.33 | −$141.3K | −100.0%0 after |